There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

Pictured are some of the members of the Sterling Lions Club Parkinson’s Exercise Group. Because exercise is known to be the ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...

Some Diabetes Drugs Tied to Lower Risk of Dementia, Parkinson's Disease Sep. 18, 2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease ...

Parkinson’s disease (PD) is a progressive disorder of ... Studies show that moderate to vigorous cardiovascular exercise can slow disease progression — in some patients, for up to a year.

Sprenger Healthcare Elms Retirement Village is accepting sign-ups for a Take Control with Total Parkinson’s exercise class ...

Spanning nearly 100 laboratories in 45 countries, landmark research has, for the first time, shown an association between genetic brain size and neurological conditions such as Parkinson's disease ...

Research led by the University of Michigan has provided compelling evidence that could solve a fundamental mystery in the makeup of fibrils that play a role in Alzheimer's, Parkinson's and other ...

Alzheimer’s disease and Parkinson’s disease are both neurodegenerative diseases. They’re similar in terms of symptoms, treatment, risk factors, and outlook. But there are also differences.

Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help people ...

PDF files have become a major part of our digital lives in this cross-platform world. While simply viewing or commenting on a PDF can be accomplished with free software, there are times when we ...

The Food and Drug Administration approved a drug produced by AbbVie for the treatment of late stage Parkinsons disease the company announced Thursday. The regulator approved Vyalev, also known as ...